Star Combo Pharma Ltd
ASX:S66
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.11
0.17
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Star Combo Pharma Ltd
Star Combo Pharma Ltd
Cost of Revenue
Star Combo Pharma Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Star Combo Pharma Ltd
ASX:S66
|
Cost of Revenue
-AU$20.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Bioxyne Ltd
ASX:BXN
|
Cost of Revenue
-AU$5.9m
|
CAGR 3-Years
-79%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-17%
|
|
|
McPherson's Ltd
ASX:MCP
|
Cost of Revenue
-AU$68.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
|
Elixinol Wellness Ltd
ASX:EXL
|
Cost of Revenue
-AU$4.8m
|
CAGR 3-Years
17%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
B
|
Biome Australia Ltd
ASX:BIO
|
Cost of Revenue
-AU$5.1m
|
CAGR 3-Years
-65%
|
CAGR 5-Years
-97%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hydration Pharmaceuticals Co Ltd
ASX:HPC
|
Cost of Revenue
-$4.6m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Star Combo Pharma Ltd
Glance View
Star Combo Pharma Ltd. engages in the manufacture and distribution of vitamis, dietary supplements, and skincare products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2018-05-16. The firm develops, manufactures, and distributes a range of branded vitamins, dietary supplements, and skincare products, serving both domestic and offshore markets. The firm operates through two segments: Star Combo business and Austoyou retail. Star Combo business segment includes developing, manufacturing, marketing and sales of natural health supplements and skin care products. Austoyou retail business made up of the Australia-China e-commerce platform that offers products directly to Chinese health product consumers; and Koala Mall’s two retail stores in Sydney. Its products include Costar NMN, Costar osteo comples Gluco, Living Healthy and Little, Amax Top Marine Collagen E ,J&K Ultra nourishing colla and J&K Rose Oil Lanolin Cream. The company also provides Original Equipment Manufacturer (OEM) Services and Quality Assurance.
See Also
What is Star Combo Pharma Ltd's Cost of Revenue?
Cost of Revenue
-20.3m
AUD
Based on the financial report for Jun 30, 2024, Star Combo Pharma Ltd's Cost of Revenue amounts to -20.3m AUD.
What is Star Combo Pharma Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-3%
Over the last year, the Cost of Revenue growth was -2%. The average annual Cost of Revenue growth rates for Star Combo Pharma Ltd have been 5% over the past three years , -3% over the past five years .
You don't have any saved screeners yet